申请人:——
公开号:US20030208082A1
公开(公告)日:2003-11-06
This invention relates to a compound and the use of the compound of the formula
1
wherein R
1
, R
2
, R
3
, R
4
and R
5
are as defined in the description, A signifies —CH═CH— or —C═C—; and B signifies
2
wherein R
6
to R
26
, X and Y are as defined In the specification or a pharmaceutically acceptable salt thereof, for use in pharmaceutical compositions for the treatment or prevention of mGluR5 receptor mediated disorders.
本发明涉及一种化合物及其公式1中的化合物的使用,其中R1、R2、R3、R4和R5如说明书中所定义,A表示—CH═CH—或—C═C—; B表示2,其中R6至R26、X和Y如规范所定义,或其药学上可接受的盐,用于制备药物组合物,用于治疗或预防mGluR5受体介导的疾病。